RE:RE:RE:May as well make a weekly video on SBMBottom line is this: SBM has exactly ONE binding, signed deal, and that is SGLT2 with Wanbang. No real bucks coming into the coffers with that one for at least 2-3 years. Sure, the milestones are nice, but not company makers, not even company sustainers.
Everything else heard to date on 1067 is either MOU's or non-binding term sheets - essentially not worth the paper they're written on (remember the Allergan term sheet exchanges lol???).
We're sitting at near the half dollar mark with hope that this time will be the lucky charm. There certainly is some cautious optimism built into the price. However, the pop we hear when a binding contract is announced will be significant. Once credibility is established, the ensuing pops on successive deals will be mind boggling IMHO, with some real thoroughbreds driving the future pipeline. Hang on to your seats!